The invasive and tumor sphere-forming abilities of HNSCC cells, enhanced by TNS4 overexpression, were significantly attenuated upon treatment with the TGFβ signaling inhibitor LY2109761 (Figure 5C, 5D). Here, TGFB1 is linked to head and neck squamous cell carcinoma.